Lizhu Pharmaceutical Group Co., Ltd

Livzon

Lizhu Pharmaceutical Group Co., Ltd., established in 1985, is a famous trademark, listed company and high-tech enterprise in Guangdong Province. It has outstanding advantages in the field of prescription drugs. It is well-known in the pharmaceutical industry of digestive tract drugs / cardio cerebrovascular drugs / anti infective drugs. It is a comprehensive pharmaceutical enterprise group.

Lizhu Pharmaceutical Group Co., Ltd. is a comprehensive pharmaceutical enterprise group integrating pharmaceutical R & D, development, production and sales. It was founded in January 1985 with a registered capital of about 300 million yuan. Lizhu group is adjacent to Hong Kong and Macao, and has obvious location advantages. Lizhu Pharmaceutical Group has established a marketing network covering the domestic market. With the continuous improvement of the quality system, the rapid growth of sales, the continuous expansion of production capacity, and the acceleration of the construction of the new factory, Lizhu Pharmaceutical Group is about to move the new factory as a whole. The new factory covers an area of 427000 square meters, building a world-class modern pharmaceutical production base, which marks the progress of Lizhu Pharmaceutical Group Entering a new stage of development, Lizhu group will become a leading modern pharmaceutical enterprise in China and the world. Lizhu group has ranked among the top 10 listed enterprises in China, the top 10 best listed enterprise governance, Guangdong high-tech enterprises, Guangdong pharmaceutical industry outstanding contribution enterprises, China Pharmaceutical Industry (Sales) top 100 enterprises, and Guangdong pharmaceutical industry comprehensive strength top 50. At present, Lizhu group is undergoing strategic transformation. On the one hand, Lizhu Group continues to maintain its existing advantages and make a big increase. On the other hand, Lizhu group quickly enters the forefront of monoclonal antibodies and vaccines representing the current and future development direction of international medicine, realizes strategic transformation, advances towards the most outstanding goal of China's national pharmaceutical industry, and strives to build a great public hospital dedicated to the evergreen cause of human life Division.